Related Experiment Video

Updated: Jun 4, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Management of acute ST-elevation myocardial infarction: Reperfusion options

Dmitriy Kireyev1, Huay Cheem Tan, Kian Keong Poh

  • 1Cardiology Department, State University of New York at Buffalo, USA.

Annals of the Academy of Medicine, Singapore
|January 29, 2011
PubMed

Insights

ST-segment elevation myocardial infarction (STEMI) reperfusion strategies are crucial for patient outcomes. This review examines STEMI reperfusion therapies in Singapore, comparing them with Western practices to optimize local medical systems and patient profiles.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Public Health

Background:

  • ST-segment elevation myocardial infarction (STEMI) requires prompt reperfusion.
  • Primary percutaneous coronary intervention (PCI) and thrombolysis are standard treatments.
  • Clinical outcomes depend on reperfusion time and strategy effectiveness.

Purpose of the Study:

  • To review reperfusion strategies for acute STEMI in Singapore.
  • To compare Singapore's clinical application with Western countries.
  • To optimize reperfusion strategies considering local systems and patient profiles.

Main Methods:

  • Literature review of reperfusion strategies.
  • Historical analysis of STEMI management in Singapore.
  • Comparative analysis with developed Western countries.

Main Results:

  • STEMI management has evolved with advancements in reperfusion.
  • Singapore's approach to STEMI reperfusion is influenced by local factors.
  • Variations exist in the application of reperfusion strategies globally.

Conclusions:

  • Optimizing STEMI reperfusion requires tailored strategies.
  • Local medical systems and patient profiles are key considerations.
  • Continuous evaluation and comparison with international practices are essential for improving STEMI care.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...